These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 19958999)

  • 1. Debate on measures of outcome.
    Tugwell P; Knottnerus JA; Wells G; Idzerda L
    J Clin Epidemiol; 2010 Jan; 63(1):1. PubMed ID: 19958999
    [No Abstract]   [Full Text] [Related]  

  • 2. Different measures of treatment effect for different research questions.
    Austin PC
    J Clin Epidemiol; 2010 Jan; 63(1):9-10. PubMed ID: 19837563
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Editorial comment by Dr Menicanti.
    D'Errigo P; Seccareccia F; Fusco D; Perucci CA
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):468-9; author reply 469. PubMed ID: 18515130
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness of drug abuse treatment: relevant issues and alternative longitudinal modeling approaches.
    Hser YI; Anglin MD
    NIDA Res Monogr; 1991; 113():67-93. PubMed ID: 1762644
    [No Abstract]   [Full Text] [Related]  

  • 5. Do we need the new Italian risk stratification model for CABG patients?
    Hekmat K; Mehlhorn U; Wahlers T
    Eur J Cardiothorac Surg; 2006 May; 29(5):856-7; author reply 857-8. PubMed ID: 16600609
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy endpoint selection and multiplicity adjustment methods in clinical trials with inherent multiple endpoint issues.
    Sankoh AJ; D'Agostino RB; Huque MF
    Stat Med; 2003 Oct; 22(20):3133-50. PubMed ID: 14518019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring youth outcomes from alcohol and drug treatment.
    Brown SA
    Addiction; 2004 Nov; 99 Suppl 2():38-46. PubMed ID: 15488104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter to editor re: "comparison of mortality prediction models after open abdominal aortic aneurysm repair".
    Tang TY; Walsh SR; Boyle JR
    Eur J Vasc Endovasc Surg; 2007 Sep; 34(3):379. PubMed ID: 17574452
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimal designs for clinical trials with second-order polynomial treatment effects.
    Winkens B; Schouten HJ; van Breukelen GJ; Berger MP
    Stat Methods Med Res; 2007 Dec; 16(6):523-37. PubMed ID: 17698939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hierarchical modeling: its time has come.
    DeLong E
    Am Heart J; 2003 Jan; 145(1):16-8. PubMed ID: 12514649
    [No Abstract]   [Full Text] [Related]  

  • 11. Updated methods for reporting clinical trials.
    Hait WN
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6753-4. PubMed ID: 16203758
    [No Abstract]   [Full Text] [Related]  

  • 12. [Roaming through methodology. XXV. Outcome measures, surrogate outcomes, and intermediate measures].
    Boers M
    Ned Tijdschr Geneeskd; 2000 Oct; 144(41):1949-52. PubMed ID: 11048558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A methodology for analysing a repeated measures and survival outcome simultaneously.
    Rochon J; Gillespie BW
    Stat Med; 2001 Apr; 20(8):1173-84. PubMed ID: 11304734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards an epidemiology of rheumatoid arthritis outcome with respect to treatment: randomized controlled trials overestimate treatment response and effectiveness.
    Wolfe F; Michaud K
    Rheumatology (Oxford); 2005 Dec; 44 Suppl 4():iv18-iv22. PubMed ID: 16306476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence is the preferred measure of frequency of birth defects.
    Mason CA; Kirby RS; Sever LE; Langlois PH
    Birth Defects Res A Clin Mol Teratol; 2005 Oct; 73(10):690-2. PubMed ID: 16240384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invited commentary for "From innumeracy to insight: the uncertainty of help versus harm in treatment of asymptomatic aortic aneurysms" by Legemate and Bossuyt.
    Björck M; Wanhainen A
    Eur J Vasc Endovasc Surg; 2006 Dec; 32(6):624-6. PubMed ID: 16931072
    [No Abstract]   [Full Text] [Related]  

  • 17. Consequences of dichotomization.
    Fedorov V; Mannino F; Zhang R
    Pharm Stat; 2009; 8(1):50-61. PubMed ID: 18389492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How useful are retrospective studies in evaluating therapeutic interventions?
    Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Mar; 3(1):3. PubMed ID: 12061942
    [No Abstract]   [Full Text] [Related]  

  • 19. Complementary and alternative medicine whole systems research: beyond identification of inadequacies of the RCT.
    Verhoef MJ; Lewith G; Ritenbaugh C; Boon H; Fleishman S; Leis A
    Complement Ther Med; 2005 Sep; 13(3):206-12. PubMed ID: 16150375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical usage of O'Brien's OLS and GLS statistics in clinical trials.
    Dallow NS; Leonov SL; Roger JH
    Pharm Stat; 2008; 7(1):53-68. PubMed ID: 17390306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.